A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy Regimens in Metastatic Pancreatic Ductal Adenocarcinoma Patients
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 03 Feb 2017
At a glance
- Drugs Anakinra (Primary) ; Fluorouracil (Primary) ; Irinotecan (Primary) ; Oxaliplatin (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions
- 30 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 30 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
- 10 Aug 2016 New trial record